Literature DB >> 25683643

Cardiovascular risk assessments in chronic myeloid leukemia allow identification of patients at high risk of cardiovascular events during treatment with nilotinib.

Massimo Breccia1, Gioia Colafigli, Matteo Molica, Giuliana Alimena.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25683643     DOI： 10.1002/ajh.23976

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  Comparative Assessment of Echocardiographic Patterns Among Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor and Healthy Controls.

Authors:  Abayomi O Bamgboje; Muheez A Durosinmi; Tuoyo O Mene-Afejuku; Micheal O Fagbayimu; Olusola Fajobi; Michael O Balogun
Journal:  Vasc Health Risk Manag       Date:  2022-02-15

Review 2.  Tyrosine Kinase Inhibitors and Vascular Toxicity: Impetus for a Classification System?

Authors:  Joerg Herrmann
Journal:  Curr Oncol Rep       Date:  2016-06       Impact factor: 5.075

Review 3.  Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.

Authors:  Joerg Herrmann; Eric H Yang; Cezar A Iliescu; Mehmet Cilingiroglu; Konstantinos Charitakis; Abdul Hakeem; Konstantinos Toutouzas; Massoud A Leesar; Cindy L Grines; Konstantinos Marmagkiolis
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

4.  Association between a cardiovascular disease risk assessment and the molecular response to tyrosine kinase inhibitors in chronic-phase chronic myeloid leukemia patients.

Authors:  Yuki Osada; Hideki Arakaki; Satoshi Takanashi; Chisako Ito; Yoshinobu Aisa; Tomonori Nakazato
Journal:  Med Oncol       Date:  2017-03-22       Impact factor: 3.064

5.  Nilotinib as a risk factor for ischaemic stroke: A series of three cases.

Authors:  J B Gómez-Galván; S Borrego; N Tovar; L Llull
Journal:  Neurologia       Date:  2016-01-06       Impact factor: 3.109

Review 6.  Challenges and Management of Acute Coronary Syndrome in Cancer Patients.

Authors:  Isabela Bispo Santos da Silva Costa; Fernanda Thereza de Almeida Andrade; Diego Carter; Vinicius B Seleme; Maycon Santos Costa; Carlos M Campos; Ludhmila Abrahão Hajjar
Journal:  Front Cardiovasc Med       Date:  2021-06-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.